RLS Global Q4’21: Progressing According to Plan - Redeye
Redeye provides its comments on RLS’s Q4’21 report. With an imminent European launch of ChloraSolv together with ConvaTec, 2022 will likely be RLS’s most interesting year so far. We reiterate our Base Case.
ANNONS
Redeye provides its comments on RLS’s Q4’21 report. With an imminent European launch of ChloraSolv together with ConvaTec, 2022 will likely be RLS’s most interesting year so far. We reiterate our Base Case.